• Register
  • Login

Iranian Journal of Pharmaceutical Sciences

  • Home
  • Journal Info
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Indexing & Abstracting
    • Privacy Statement
    • Contact us
  • Issues
    • Current
    • Archives
  • New Submissions
  • Author Guidelines
  • Policies & Process
    • Peer Review
    • Publication Ethics
    • Open Access Policy
    • Plagiarism
    • Retraction Policies
    • Archiving
  • Ethical Considration
Advanced Search
  1. Home
  2. Archives
  3. Vol. 20 No. 3 (2024): IJPS_Volume 20_Issue 3 (2024)
  4. Research/Original Articles

Vol. 20 No. 3 (2024)

September 2024

Formulation Development and in-vivo/in-vitro Characterization of Novel Glucose Responsive Hydrogel for Insulin Delivery Glucose Responsive Insulin Delivery

  • Rupesh A. Saindane
  • Sharwaree R. Hardikar

Iranian Journal of Pharmaceutical Sciences, Vol. 20 No. 3 (2024), 22 September 2024 , Page 227- 241
https://doi.org/10.22037/ijps.v20i3.44381 Published: 2024-07-01

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Glucose-responsive delivery systems intelligently regulate insulin release in response to fluctuating blood glucose levels, offering a more controlled approach to diabetes management. The current study introduces a novel glucose-responsive hydrogel system for enhanced insulin delivery. The hydrogel, formulated from chitosan and Poloxamer 407, exhibits unique thermo-responsive and pH-sensitive characteristics, making it suitable for subcutaneous insulin delivery. The research encompasses comprehensive in vitro and in vivo analyses to evaluate the formulation's efficacy and responsiveness to glucose concentrations. In vitro studies demonstrated that the hydrogel's solubilization rate varies with pH and glucose levels, crucial for controlled insulin release. Notably, the hydrogel exhibited an extended and more stable control of blood glucose levels compared to conventional insulin treatments. One significant finding is the hydrogel's rapid in vivo gelation and biodegradability, indicating its safety and effectiveness in a physiological environment. In vivo experiments conducted on diabetic rats showcased the hydrogel's glucose-responsive behavior. Moreover, the hydrogel's ability to modulate insulin release in response to changing glucose levels was distinct from traditional insulin therapies, highlighting its potential to manage multiple hyperglycemic episodes after a single dose. Overall, this research marks a significant advancement in insulin delivery systems. The development of this glucose-responsive hydrogel system presents a promising approach for achieving more controlled and stable blood glucose levels in individuals with diabetes, potentially enhancing their quality of life. The findings suggest opportunities for further optimization, particularly in insulin content, to tailor the system to the specific needs of the diabetic population.

Keywords:
  • Glucose-responsive delivery
  • Insulin
  • pH-Sensitive hydrogels
  • Diabetes
  • Chitosan
  • Poloxamer
  • IJPS_Volume20_Issue3_ Pages 227- 241

How to Cite

Saindane, R. A., & Hardikar, S. R. (2024). Formulation Development and in-vivo/in-vitro Characterization of Novel Glucose Responsive Hydrogel for Insulin Delivery: Glucose Responsive Insulin Delivery. Iranian Journal of Pharmaceutical Sciences, 20(3), 227–241. https://doi.org/10.22037/ijps.v20i3.44381
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

World Health Organization (WHO). Health Topics, Diabetes. https://www.who.int/health-topics/diabetes#tab=tab_1 (Accessed February 24, 2023).

World Health Organization (WHO). Global Report on Diabetes. https://www.who.int/publications/i/item/9789241565257 (Accessed February 24, 2023).

Yaturu S. Insulin therapies: Current and future trends at dawn. World J. Diabetes (2013) 4:1.

Wang J, Wang Z, Yu J, Kahkoska AR, Buse JB, Gu Z. Glucose‐Responsive Insulin and Delivery Systems: Innovation and Translation. Advanced Materials (2020) 32:1902004.

Chou DH-C, Webber MJ, Tang BC, Lin AB, Thapa LS, Deng D, Truong JV, Cortinas AB, Langer R, Anderson DG. Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates. Proceedings of the National Academy of Sciences (2015) 112:2401–2406.

Mansoor S, Kondiah PPD, Choonara YE. Advanced Hydrogels for the Controlled Delivery of Insulin. Pharmaceutics (2021) 13:2113.

Mohanty AR, Ravikumar A, Peppas NA. Recent advances in glucose-responsive insulin delivery systems: novel hydrogels and future applications. Regen Biomater. https://doi.org/10.1093/rb/rbac056.

Albin GW, Horbett TA, Miller SR, Ricker NL. Theoretical and experimental studies of glucose sensitive membranes. Journal of Controlled Release (1987) 6:267–291.

Traitel T, Cohen Y, Kost J. Characterization of glucose-sensitive insulin release systems in simulated in vivo conditions. Biomaterials (2000) 21:1679–1687.

Elshaarani T, Yu H, Wang L, Feng J, Li C, Zhou W, Khan A, Usman M, Amin BU, Khan R. Chitosan reinforced hydrogels with swelling-shrinking behaviors in response to glucose concentration. Int. J. Biol. Macromol. (2020) 161:109–121.

Kumar MNVR, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan Chemistry and Pharmaceutical Perspectives. Chem. Rev. (2004) 104:6017–6084.

Lee JI, Kim HS, Yoo HS. DNA nanogels composed of chitosan and Pluronic with thermo-sensitive and photo-crosslinking properties. Int. J. Pharm. (2009) 373:93–99.

Yoo HS. Photo-cross-linkable and thermo-responsive hydrogels containing chitosan and Pluronic for sustained release of human growth hormone (hGH). J. Biomater. Sci. Polym. Ed. (2007) 18:1429–1441.

Park KM, Lee SY, Joung YK, Na JS, Lee MC, Park KD. Thermosensitive chitosan–Pluronic hydrogel as an injectable cell delivery carrier for cartilage regeneration. Acta Biomater. (2009) 5:1956–1965.

García-Couce J, Tomás M, Fuentes G, Que I, Almirall A, Cruz LJ. Chitosan/Pluronic F127 Thermosensitive Hydrogel as an Injectable Dexamethasone Delivery Carrier. Gels (2022) 8:44.

Brambilla E, Locarno S, Gallo S, Orsini F, Pini C, Farronato M, Thomaz DV, Lenardi C, Piazzoni M, Tartaglia G. Poloxamer-Based Hydrogel as Drug Delivery System: How Polymeric Excipients Influence the Chemical-Physical Properties. Polymers (Basel) (2022) 14:3624.

Schmolka IR. Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J. Biomed. Mater. Res. (1972) 6:571–582.

Jeong B, Bae YH, Kim SW. Thermoreversible Gelation of PEG−PLGA−PEG Triblock Copolymer Aqueous Solutions. Macromolecules (1999) 32:7064–7069.

Giovagnoli S, Tsai T, DeLuca PP. Formulation and Release Behavior of Doxycycline–Alginate Hydrogel Microparticles Embedded into Pluronic F127 Thermogels as a Potential New Vehicle for Doxycycline Intradermal Sustained Delivery. AAPS PharmSciTech (2010) 11:212–220.

Kashyap N, Viswanad B, Sharma G, Bhardwaj V, Ramarao P, Ravi Kumar MNV. Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin. Biomaterials (2007) 28:2051–2060.

OECD Test Guidelines for Chemicals (2001).

Kim JS, Ju JB, Choi CW, Kim SC. Hypoglycemic and Antihyperlipidemic Effect of Four Korean Medicinal Plants in Alloxan Induced Diabetic Rats. Am. J. Biochem. Biotechnol. (2006) 2:154–160.

Hatakeyama H, Hatakeyama T. Interaction between water and hydrophilic polymers. Thermochim. Acta (1998) 308:3–22.

Gun’ko V, Savina I, Mikhalovsky S. Properties of Water Bound in Hydrogels. Gels (2017) 3:37.

Zoldák G, Zubrik A, Musatov A, Stupák M, Sedlák E. Irreversible Thermal Denaturation of Glucose Oxidase from Aspergillus niger Is the Transition to the Denatured State with Residual Structure. J. Biol. Chem. (2004) 279:47601–47609.

Cook MT, Haddow P, Kirton SB, McAuley WJ. Polymers Exhibiting Lower Critical Solution Temperatures as a Route to Thermoreversible Gelators for Healthcare. Adv. Funct. Mater. (2021) 31:2008123.

Taylor M, Tomlins P, Sahota T. Thermoresponsive Gels. Gels (2017) 3:4.

Kühl PW. Excess-substrate inhibition in enzymology and high-dose inhibition in pharmacology: a reinterpretation. Biochem. J. (1994) 298:171–180.

Shen D, Yu H, Wang L, Khan A, Haq F, Chen X, Huang Q, Teng L. Recent progress in design and preparation of glucose-responsive insulin delivery systems. J. Control. Release (2020) 321:236–258.

  • Abstract Viewed: 395 times
  • IJPS_Volume20_Issue3_ Pages 227- 241 Downloaded: 368 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Print ISSN: 1735-2444

Online ISSN: 2252-0457

Powered by OJSPlus